Research that Makes a Difference in the Lives of Cancer Patients. Providing new solutions to solve today’s problems in fighting cancer.
Genprex is a privately held, clinical-stage biopharmaceutical company developing nanomolecular therapies that control universal cancer pathways to unlock the unrealized potential of a variety of targeted cancer therapies. Our tumor suppressors are pan-kinase inhibitors that work to induce apoptosis in cancer cells and control cell signaling and inflammatory pathways. Our drugs are used in combination with other targeted cancer therapies.